Embody vs Ivim Health: GLP-1 Prices Compared

• Foundayo via Ivim Health

  Orforglipron · Telehealth (branded)

  

  Ivim Health

  Advertised price$223.99/mo

  Calculated: $149 medication + $74.99 ongoing membership/provider fee (ivimhealth.com). Charges billed separately.

  Separate billing cycles; excluded from cost ranking.

  Checked Nov 4, 2026

  Maintenance price$373.99/mo

  At 17.2 mg

  Calculated: $299 medication + $74.99 ongoing membership/provider fee (ivimhealth.com). Charges billed separately.

  Separate billing cycles; excluded from cost ranking.

  Checked Nov 4, 2026

  View offer
  Price conditions & source

  Maintenance terms: $299 of medication from 9 mg up; $199 at 5.5 mg.

  A 1-month supply at 0.8 mg ($149 of medication at 2.5 mg too). FDA-approved product.

  Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

  Read the advertised-price source (ivimhealth.com)
• Wegovy pill via Ivim Health

  Semaglutide · Telehealth (branded)

  

  Ivim Health

  Advertised price$223.99/mo

  Calculated: $149 medication + $74.99 ongoing membership/provider fee (ivimhealth.com). Charges billed separately.

  Separate billing cycles; excluded from cost ranking.

  Checked Nov 4, 2026

  Maintenance price$373.99/mo

  At 25 mg

  Calculated: $299 medication + $74.99 ongoing membership/provider fee (ivimhealth.com). Charges billed separately.

  Separate billing cycles; excluded from cost ranking.

  Checked Nov 4, 2026

  View offer
  Price conditions & source

  A 1-month supply at 1.5 mg; $199 of medication at 4 mg on this product line, though another Ivim page lists 4 mg at $149. FDA-approved product.

  Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

  Read the advertised-price source (ivimhealth.com)
• Zepbound KwikPen via Ivim Health

  Tirzepatide · Telehealth (branded)

  

  Ivim Health

  Advertised price$373.99/mo

  Calculated: $299 medication + $74.99 ongoing membership/provider fee (ivimhealth.com). Charges billed separately.

  Separate billing cycles; excluded from cost ranking.

  Checked Nov 4, 2026

  Maintenance price$523.99/mo

  At 15 mg

  Calculated: $449 medication + $74.99 ongoing membership/provider fee (ivimhealth.com). Charges billed separately.

  Separate billing cycles; excluded from cost ranking.

  Checked Nov 4, 2026

  View offer
  Price conditions & source

  Maintenance terms: Ivim lists $449 of medication at 7.5 to 15 mg, for vials and KwikPens alike.

  A 1-month supply at 2.5 mg; the medication prices match Eli Lilly's own self-pay prices. FDA-approved product.

  Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

  Read the advertised-price source (ivimhealth.com)
• Compounded semaglutide via Embody

  Semaglutide · Compounded

  Compounded · Not FDA-approved

  

  Embody

  Partner

  Advertised priceflat rate at $49/month

  Supply period unverified; excluded from cost ranking.

  Checked Nov 4, 2026

  Maintenance price

  No separate dose price verified

  View offer
  Price conditions & source

  Advertised price: flat monthly rate for weekly GLP-1 injections on Embody's homepage, under a "Pre-Black Friday Sale" (save $200 instantly) with no end date; the plan length is not stated; no hidden fees, shipped to your door

  Weekly injection. The product pages this price came from on Oct 16, 2026 (a 1-month supply at $79 on sale, or $69 to $76 a month on 3- to 12-month supplies) no longer load, and the homepage shows only this flat rate. Embody's Terms (updated April 24, 2026) state different prices: $99 the first month then $299 a month, or a flat $199 a month. Not available in every state. Compounded; not FDA-approved.

  Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

  Read the advertised-price source (joinem.co)
• Compounded semaglutide via Ivim Health

  Semaglutide · Compounded

  Compounded · Not FDA-approved

  

  Ivim Health

  Advertised price$224.99/mo

  Calculated: $150 medication + $74.99 ongoing membership/provider fee (ivimhealth.com). Charges billed separately.

  Separate billing cycles; excluded from cost ranking.

  Checked Nov 4, 2026

  Maintenance price

  No separate dose price verified

  View offer
  Price conditions & source

  1-month program. On 12 months the medication is $780 ($65 a month) plus $899.88 of membership, $1,679.88 in all; compounded programs are paid upfront and the membership runs for the whole plan. Other Ivim pages show $75, $140 or $149 a month for semaglutide. Compounded; not FDA-approved.

  Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

  Read the advertised-price source (ivimhealth.com)
• Compounded tirzepatide via Embody

  Tirzepatide · Compounded

  Compounded · Not FDA-approved

  

  Embody

  Partner

  Advertised priceflat rate at $99/month

  Supply period unverified; excluded from cost ranking.

  Checked Nov 4, 2026

  Maintenance price

  No separate dose price verified

  View offer
  Price conditions & source

  Advertised price: flat monthly rate for weekly GLP-1 / GIP injections on Embody's homepage, under a "Pre-Black Friday Sale" (save $200 instantly) with no end date; the plan length is not stated; no hidden fees, shipped to your door

  Weekly injection. The product pages this price came from on Oct 16, 2026 (a 1-month supply at $129 on sale, or $119 to $126 a month on 3- to 12-month supplies) no longer load, and the homepage shows only this flat rate. Embody's Terms (updated April 24, 2026) state different prices: $149 the first month then $399 a month, or the flat semaglutide price plus $100 a month. Not available in every state. Compounded; not FDA-approved.

  Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

  Read the advertised-price source (joinem.co)
• Compounded tirzepatide via Ivim Health

  Tirzepatide · Compounded

  Compounded · Not FDA-approved

  

  Ivim Health

  Advertised price$324.99/mo

  Calculated: $250 medication + $74.99 ongoing membership/provider fee (ivimhealth.com). Charges billed separately.

  Separate billing cycles; excluded from cost ranking.

  Checked Nov 4, 2026

  Maintenance price

  No separate dose price verified

  View offer
  Price conditions & source

  1-month program. On 12 months the medication is $1,400 (about $117 a month) plus $899.88 of membership, $2,299.88 in all, paid upfront. Other Ivim pages show $133 or $192 a month for tirzepatide. Compounded; not FDA-approved.

  Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

  Read the advertised-price source (ivimhealth.com)

The FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved, ending the exemption that let pharmacies mass-produce compounded copies, and the 503A/503B enforcement-discretion grace periods ended in 2025. The FDA is now actively enforcing (warning letters and takedowns, including a September 2026 warning letter to Empower Pharmacy, a large compounder, over products it called essentially copies of approved semaglutide and tirzepatide), and in 2026 proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list (the public comment period, extended 30 days, closed July 30, 2026; a final decision is pending). Liraglutide is different: it is still on the FDA drug shortage list (brand Victoza and Saxenda in limited supply, generics available, as of October 2026). Compounded GLP-1s are not FDA-approved and are now generally limited to narrow, patient-specific 503A prescriptions, so broad low-cost availability has largely wound down. They also carry safety risks the branded products do not: FDA adverse-event reports, at least one sterility recall (ProRx, October 2025), and counterfeit product found in the US supply chain, so a low price is not a low-risk signal. Prices and availability below may lag these changes; confirm current terms with the provider.

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. The default order of a list is by price, lifted by a referral boost for the sellers that pay us, and says so beside the list; every lowest-cost sort reads the price alone. Every partner is labeled. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.